Torrent Pharmaceuticals Limited Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals Limited

TORNTPHARM

주식 순위 #1200
Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity,... Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity, managing the entire process from the discovery and development of generic drug formulations to their production and distribution. Its commercial activities extend across key markets such as India, the United States, Germany, and Brazil, alongside various other international territories. The company boasts a broad product catalog, offering treatments for a wide array of medical conditions. This includes therapies for cardiovascular diseases, central nervous system disorders, gastrointestinal issues, women's health concerns, diabetes, pain management, gynecological ailments, oncology, and anti-infective medications. Additionally, Torrent Pharma supplies essential vitamins, minerals, and other nutritional supplements. Beyond its proprietary offerings, the firm also provides contract manufacturing services to other companies. During the COVID-19 pandemic, it demonstrated its commitment by securing licensing agreements for crucial treatments like Baricitinib, Molnupiravir, and Paxlovid. Established in 1959, the company originally operated under the name Trinity Laboratories before officially becoming Torrent Pharmaceuticals Limited in 1971. Its corporate headquarters are located in Ahmedabad, India. Ultimately, Torrent Pharmaceuticals Limited functions as a subsidiary of Torrent Investments Private Limited.
주가
$50.31
마지막 동기화: 2026-10-19
시가총액
$19.14B
변동 (1일)
-0.14%
변동 (1년)
23.32%
국가
IN
거래 Torrent Pharmaceuticals Limited (TORNTPHARM)

카테고리

Healthcare
Torrent Pharmaceuticals Limited (TORNTPHARM)의 주식 분할 이력
Torrent Pharmaceuticals Limited 주식 (심볼: TORNTPHARM)은 총 3회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Jul 08, 2022에 발생했습니다.
Feb 20, 2006 이전에 매수한 TORNTPHARM 주식 1주는 현재 8주의 TORNTPHARM 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
2022-07-08 2:1 x2 x8
2013-07-23 2:1 x2 x4
2006-02-20 2:1 x2 x2
유사 기업 또는 경쟁사의 주식 분할